Search Results 281-290 of 1137 for ai制作网格,ai翻唱网站,ai 写作网,ai工具合集官网,ai编歌网站,等欢迎访问豌豆Ai站群搜索引擎系统官方网站:www.wd.chat

  1. Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. Clinical Utility of the SPEAC® System: A Case Series

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors - Mayo Clinic

    The purpose of this study is evaluating a drug called ART0380 in participants with advanced or metastatic solid tumors. Mayo Clinic will be pariticipating in ...

  4. A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma - Mayo Clinic

    This is a multi-center, open label, single arm phase II study evaluating BGJ398 anti-tumor activity in advanced or metastatic cholangiocarcinoma patients with ...

  5. Hancheng Cai, Ph.D. - Doctors and Medical Staff - Mayo Clinic

    Hancheng Cai, PhD, is a radiochemist and molecular imaging scientist. My clinical work focus on FDA cGMP PET drug production facility implementation and ...

  6. A Study to Evaluate Durvalumab plus Topotecan or Lurbinectedin in Patients with Small Cell Lung Cancer - Mayo Clinic

    The purpose of this study is to evaluate whether the combination of durvalumab plus lurbinectedin can increase 6 month progression-free survival, in patients ...

  7. Publications - Xiaoying Liang, Ph.D. - Mayo Clinic

    Liu C, Beltran CJ, Shen J, Zhang N, Pi Y, Bues M, Park J, Lu B, Yaddanapudi S, Tan J, Furutani KM, Liang X. Worst-Case Robustness Evaluation Methods for ...

  8. Anne Gingery, Ph.D. - Mayo Clinic Faculty Profiles

    Mayo Clinic's Anne Gingery, Ph.D., focuses on studying the impacts of aging, cellular senescence, immune dysregulation and metabolic dysfunction in ...

  9. Brain tumor - Doctors and departments - Mayo Clinic

    Mayo Clinic Comprehensive Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center. This designation ...

  10. A Study Using the New TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients with Metastatic, Persistent, Recurrent, or Progressive Solid Tumors - Mayo Clinic

    About this study. This phase Ib trial studies the best way of TLR8 Agonist VTX-2337 and cyclophosphamide in treating patients with a solid tumor that has ...